Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Cladribine Tablets
DRUG
2 trials
Sponsors
EMD Serono Research & Development Institute, Inc.
, Keith Edwards, M.D.
Conditions
Multiple Sclerosis
Phase 4
A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets
NCT04550455
Keith Edwards, M.D.
Multiple Sclerosis
Start: 2020-09-16
End: 2025-12-31
Target: 30
Updated: 2022-01-13
Unknown Phase
A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)
Completed
NCT03933202
EMD Serono Research & Development Institute, Inc.
Multiple Sclerosis
Start: 2019-07-22
End: 2024-11-11
Updated: 2026-01-02
Related Papers
CLICK-MS and MASTER-2 Phase IV Trial Design: Cladribine Tablets in Suboptimally Controlled Relapsing Multiple Sclerosis
Neurodegenerative Disease Management
2021-02-01
6 citations